Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'
NCT02341547
·
clinicaltrials.gov ↗
UNKNOWN
Status
44
Enrollment
OTHER_GOV
Sponsor class
Conditions
End Stage Renal Failure
Anaemia
Interventions
DRUG:
a Biosimilar Epoetin Alfa
Sponsor
Penang Hospital, Malaysia